In particular our HuCAL technology allows novel antibodies to be generated much faster than the current standard procedures. These can be provided in a range of formats according to specified needs.
Antibodies are available in small or bulk quantities for single use or for manufacturing on behalf of diagnostic customers. The custom services facility aids customers with specific antibody development challenges. AbD Serotec currently has relationships with more than 20 diagnostic companies.
With the acquisition of Sloning BioTechnology in 2010, MorphoSys became the sole source of the Slonomics platform, a unique system to generate protein libraries of precisely defined composition. The AbD Serotec segment commercializes this technology in selected non-therapeutic areas such as industrial biotechnology applications.
